SCHEMBL20109995

SCHEMBL20109995

c1ccc(-c2cccc(-c3cc(-c4ccccc4)c4oc5ccc(-c6c7ccccc7c(-c7ccccc7)c7ccccc67)cc5c4c3)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 5/20 0.42
PLA2G4A P47712 5/20 0.42
PLA2G10 O15496 1/20 0.42
ALOX5 P09917 2/20 0.38
PRKDC P78527 4/20 0.38
PIM1 P11309 1/20 0.37
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
PIM3 Q86V86 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
CYP1A1 P04798 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP1B1 Q16678 2/20 0.33
PGR P06401 1/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10443090 0.96 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL20109992 0.96 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL24771720 0.94 ALOX5 (0.44) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL1787677 0.93 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL10442913 0.93 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL22707193 0.92 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALOX5PIM1
SCHEMBL20115696 0.90 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL10442750 0.89 ALOX5 (0.44) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL21252598 0.89 ALOX5 (0.43) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL26404331 0.89 ALOX5 (0.49) PLA2G2APLA2G4APLA2G10ALOX5PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023359-A1 ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER SFC CO., LTD. (KR) 2024-01-18 US disclosed
US-20230371376-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME SFC CO., LTD. (KR) 2023-11-16 US disclosed
US-20180123055-A1 COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME SFC CO., LTD. (KR) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230371376-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME PPOX, MAP1LC3A, VDAC2 PLA2G2A 1893/4885PLA2G4A 1054/4885PLA2G10 857/4885
US-20180123055-A1 COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME CYP1B1, CYP1A1, CRY2 PLA2G2A 1057/4885PLA2G4A 1308/4885PLA2G10 1475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.